Suspect-and-test checklist
Wilson disease
Autosomal recessive copper disorder. A normal ceruloplasmin does not exclude it, and no single test confirms it.
ICD-10-CME83.01Trial Friend for Clinicians
1Red flags present
Liver
Acute liver failure and blood
Brain and mind
Eyes, other organs, family
2Already labeled as
3Family to test
4Testing, in the order the sources describe
- Liver tests, CBC and INRAASLD first-line blood work alongside ceruloplasmin.Result
- Serum ceruloplasminUnder 5mg/dL is most suggestive. A normal level does not exclude it.Result
- Basal 24-hour urinary copperOver 100µg in 24 hours if symptomatic; over 40µg may count in children or without symptoms. Check creatinine.Result
- Slit-lamp exam for KF ringsExperienced observer; optical tomography is an option.Result
- ATP7B sequencingVariants on both alleles confirm it. If 1 or none is found, add deletion/duplication analysis.Result
- Leipzig score; relative exchangeable copperFor unclear cases. EASL-ERN 2025 recommends both.Result
- Liver biopsy with quantitative copperOver 250µg/g in most; under 50µg/g almost always excludes it.Result
- Brain MRI if neurologic signsBaseline and to exclude other causes.Result
- Liver failure: ALP to bilirubin and AST to ALTRatio under 4 plus over 2.2 identified Wilson disease in a 140-patient cohort. Urgent transplant evaluation.Result
5Results the sources say do not rule it out
- Normal ceruloplasmin. Seen in up to 40% of hepatic presentations.
- Urinary copper under 100µg in 24 hours. That cutoff may miss 16-23%.
- No Kayser-Fleischer rings. Often absent in hepatic cases, in most children with liver disease and in 50% of liver failure cases.
- A negative copper stain, or liver copper of 100-250µg/g. Neither excludes it.
6Specialists the sources name
Diagnosis code: E83.01 Wilson's diseaseCodes patients often carry before diagnosis are listed in the online guide.
Full guide and sourcesEvery point here is sourced in the online guide, which also has a patient note to print.
Trial Friend, trialfriend.com/for-clinicians. Key sources: AASLD 2022 guidance; EASL-ERN 2025 guideline; GeneReviews (2023); Leipzig score paper (2003); Korman 2008 acute liver failure study; all 7 with links in the online guide. Checked November 10, 2026. A reference checklist for licensed clinicians that summarizes published sources. It is not a diagnostic tool, a score or a protocol, and it does not replace clinical judgment, local practice or the prescribing information. Not coding advice. Trial Friend never receives anything written or typed on this sheet.